Approvals/CIMA-AEMPS/CISPLATINO HIKMA 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

CISPLATINO HIKMA 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: aaa6c16c242f1ae2
Drug Cima Aemps Name: CISPLATINO HIKMA 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 86466
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2021-12-21
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 1 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

CISPLATINO

1 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 21, 2021

Approval ID

aaa6c16c242f1ae2

Type

Standard